Peregrine Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.97M	Sell	456,979 -44,842	-9%	-$782K	0.24%	117
2025 Q1	$6.31M	Buy	501,821 +78,260	+18%	+$985K	0.21%	139
2024 Q4	$4.47M	Buy	+423,561	New	+$4.47M	0.13%	231